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Summary
Biodegradable osteosyntheses offer the major advantage over metal implants that
they do not require a second operation for removal. This not only saves the patient
discomfort and risk, it will also be cost reducing. In addition, complications that are
associated with metal implants such as infection due to loosening or corrosion,
sensitization to metal implant components, interference with radiotherapy, computer
tomography and magnetic resonance imaging, as well as possible mutagenic effects
are obviated. Furthermore, the use of biodegradable osteosyntheses may prevent the
onsel of osteoporosis due to stress protection.
Experimental work on biodegradable osteosyntheses in the past 25 years has
concentrated mainly on poly(cv-hydroxy acid)s, in particular poly(glycolide) (PGA)
and poly(lactide) (PLA). From about 1985 onwards, PGA and PLA based
degradable osteosyntheses have been produced that are considered strong enough to
provide adequate fixation of low to medium load bearing fractures. Clinically, these
osteosyntheses have been used for repair of maxillofacial fractures and for fixation
of epiphyseal and metaphyseal fractures. Although these osteosyntheses initially
appeared successful, subsequently problems and complications were reported such as
secondary fracture dislocation, sterile sinus formation and foreign body and
immunological reactions.
A joint research project of the Department of Polymer Chemistry of the
University of Groningen and the Department of Oral and Maxillofacial Surgery of
the University Hospital Groningen on the suitability of as-polymerized poly(L-
lactide) (PLLA) as biodegradable osteosyntheses material was initiated in 1985.
During in vitro and in vivo animal studies, favorable results regarding the
mechanical properties and biocompatibility of PLLA were obtained and,
subsequently, two patient trials were started using PLLA osteosyntheses for
treatment of zygomatic and orbital floor fractures, respectively. The treatment
initially appeared to be successful. However, three years postoperatively all patients
treated for a zygomatic fracture developed swellings at the site of the implant.
Preliminary findings suggested that the development of these swellings might have
been due to the physical nature of the highly crystalline particles still present in the
tissue in large amounts, in combination with a low degradation rate of PLLA.
The joint research on biodegradable osteosyntheses was then continued by
investigating a PLA with modified physical properties in 1991. For that purpose, rhe
investigations concentrated on as-polymerized poly(96ll4DJactide) (PLA96). Instead
of being composed entirely of L-lactide, PLA96 contains 96% L-lactide and 4% D-
lactide. Due to the incorporation of D-lactide units, PLA96 has a lower crystallinity
than PLLA and, consequently, a higher degradation rate. The altered crystalline
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structure in combination with the increased degradation rate may facilitate the in vivo
resorption of PLA96 and thereby reduce or prevent the development of late
complications.
In this thesis, several aspects concerning the potential of PLA96 as a biodegradable
osteosynthesis material were explored, with the aims:
- to investigate the mechanical and physical properties of, and the histological
reaction to, PLA96 during degradation in vitro and in vivo.
- to evaluate the long-term outcome of repair of orbital floor defects in patients
treated with resorbable PLLA implants.
- to investigate the suitability of PLA96 implants for the repair of large orbital
floor defects and, for that purpose, to develop an apparatus simulating the
human orbit with an orbital floor defect.
- to investigate the cytotoxicity of PLA96 in different stages of degradation and of
its accumulated degradation products as well as the influence of different
sterilization methods on the cytotoxicity.
- to study the influence of different sterilization methods on the material
properties and degradation characteristics of PLA96.
The incorporation of D-lactide units in the PLLA chain will in general reduce the
mechanical properties of the PLA. However, the ratio of L-lactide to D-lactide units
is not the only factor determining the material properties and degradation rate of a
PLA. Other factors of influence are the molecular weight, residual monomer and
processing conditions. Regarding this complex set of factors involved, an cxtensive
study of the material properties of PLA is required, whenever compositional changes
are made.
In chapter 2, the mechanical and physical properties of, and the histological
reaction to, PLA96 were investigated in a degradation study in vitro and in rats. The
PLA96 studied had a molecular weight (M-) of 1.5 x 106 g/mole. Test samples were
implanted subcutaneously in the back of rats or put in phosphate buffer respectively.
During the first three weeks of degradation, the mechanical and physical properties
of PLA96 showed major changes. Tensile strength (on), impact strength and M*
decreased rapidly. The heat of fusion (AH.), a measure of crystaliinity, increased
whereas the melting temperature (T.) remained almost constant. After seven weeks
of degradation, the mechanical properties were lost completely. After 55 weeks,
both water absorption and massloss had reached approximately 30%, and M* had
decreased to 15 x 103 g/mole. AH, had slightly increased further but T. remained
unchanged. The measurements during degradation in vitro did not show significant
(p>0.05) differences from the measurements during degradation in viyo. The
histological reaction to PLA96 was characterized as a mild foreign body reaction
without signs of inflammation.
Patients treated with PLLA plate/screw osteosyntheses for zygomatic fractures all
developed swellings at the site of the implant three years postoperatively. In
contrast, none of the patients treated with a PLLA implant for an orbital floor
fracture, their operation dating back between 3Vz and 6t/z years, had reported any
problems. It was decided to recall these patients for follow-up examination.
The purpose of this follow-up examination, described in chapter 3, was to
evaluate the long-term outcome of repair of orbital floor defects in patients with
resorbable PLLA implants, and to determine whether these patients showed
symptoms that could be indicative of the presence of a late tissue response. Six
patients (four women, two men; mean age, 39 years; range, 18 to 67 years) treated
with PLLA implants for orbital floor fractures participated in the follow-up
examination, consisting of an interview and a physical examination, including an
ophthalmologic and orthoptic consultation. For evaluation of the orbital tissues,
coronal spin echo T1- and T2-weighted magnetic resonance images (MRIs) were
made through both orbits. None of the patients reported any problems in the years
preceding the follow-up examination that might have indicated complications.
Physical examination of the operative site revealed no abnormalities. At
ophthalmologic and orthoptic consultation, normal eye function, without diplopia or
restriction of eye motility, was found in all patients. The MRIs showed no indication
of an abnormal or increased soft tissue reaction in the orbital resion.
An implant that is to be used for the repair of a large orbital floor defect should
preferably be very thin and, in addition, be sufficiently strong and form stable. The
use of a degradable implant is appealing, however, the available degradable orbital
floor implants can not meet the requirements stated above. PLLA implants have
been successfully used for the repair of orbital floor defects in patients, however,
PLLA degrades very slowly and has evoked unfavorable tissue reactions in patients
treated for zygomatic fractures. For this reason, the suitability of PLA96 implants
for repair of large orbital floor defects was subsequently studied. The implants were
made as thin as possible in order to minimize the amount of material to be
implanted. Information concerning the strength properties required of an orbital floor
implant was not available. Therefore, an apparatus simulating the human orbit with
an orbital floor defect was developed and put to use in this study.
In chapter 4, an in vitro study of the mechanical and physical properties of two
types of PLA96 implants and an evaluation of their suitability for repair of large
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orbital floor defects is described. Implants, 0.2 mm thick and 28 mm in diameter,
were produced by either an extrusion process (type A) or by machining (type B).
After gamma sterilization with a dose of 25 kGy they had a molecular weight (M*)
of 64 x 10r and 146 x 103 g/mole, respectively. The implants were tested over 8
weeks in an apparatus simulating the human orbit with a 3.1 cmr orbital floor defect
under a static load corresponding to a retrobulbar pressure of 13 mm Hg as well as
unloaded. Both implant types were able to counteract the applied static load without
fracturing or excessive sagging. The type A implants sagged more than the type B
implants (2.3 + 0.1 mm vs. 1.0 + 0.0 mm, p<0.01) but retained and even
increased their strength during the study whereas the type B implants showed a
gradual strength-loss. In the clinical setting the observed sagging in both types would
not have resulted in positional changes of the eyeball.
The relationship between the change in physical properties of a poly(a-hydroxy acid)
implant during degradation and the development of complications such as swelling
and sterile abscess formation at the implantation site has not yet been fully clarified.
To gain more insight into this subject, a study has been carried out into the
cytotoxicity of PLA96.
In chapter 5, the cytotoxicity of PLA96 in different stages of degradation, and
of its accumulated degradation products, was investigated. In addition, the influence
of different sterilization methods on the cytotoxicity was investigated. PLA96
samples were either sterilized by steam, ethylene oxide or gamma irradiation and
were further left untreated (M0 samples), or were predegraded for 30 h (M30
samples) or 60 h (M60 samples) at 90'C in water for injections. Extracts prepared
of the M0, M30 and M60 samples, as well as the degradation fluids obtained after
30 h (D30 fluids) and 60 h (D60 fluids) were evaluated for cytotoxicity, both
unfiltered and after filtration, in a cell growth inhibition (CGI) assay and a lactate
dehydrogenase (LDH) leakage assay using L929 mouse fibroblasts. In addition, a
physical analysis of the extracted samples and degradation fluids was performed. The
M0 extracts showed no significant CGI. CGI of the M30 extracts was high (37% to
78%) whereas CGI of the M60 extracts was moderate (6% to 33%). CGI of the D30
fluids was moderate (19% to 38%) and CGI of the D60 fluids was very high (98%
to 123%). The LDH leakage assay only responded to the D60 fluids. Filtration did
not influence the cytotoxicity of the extracts and degradation fluids. Moreover, the
cvtotoxicitv did not relate to the different sterilization methods.
Because implants must be sterile, the issue of sterilization of poly(a-hydroxy acid)
implants was addressed. Steam sterilization and ethylene oxide sterilization can
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deteriorate the material properties, since PLA is thermo- and moisture-labile.
Ethylene oxide sterilization has the additional disadvantage that toxic or even
carcinogenic residues may be left in the sterilized material. Gamma irradiation is
known to induce structural changes in polymers such as main chain scissioning and
crossJinking, which both may seriously affect the polymers' properties. A special
steam sterilization program developed for PLLA implants appeared to be also
promising for sterilization of other thermo- and moistureJabile polymers.
In chapter 6, the influence of these four sterilization methods on the material
properties and degradation characteristics of PLA96 was investigated. Specimens
were machined from blocks of as-polymerized PLA96 and were either left
unsterilized (NS) or were sterilized by regular steam (RGS), special sream (SPS),
ethylene oxide (EO) or gamma irradiation (GM). After subsequent immersion in a
phosphate buffer at 37'C, the tensile properties, impact strength, warer absorprion,
change in mass and thermal properties of the specimens were measured during 8
weeks at 2 week intervals. The fracture surfaces of cryogenically broken specimens
at week 0, 4 and 8 were examined using scanning electron microscopy (SEM). It
was found that EO sterilization had very little effect on the tensile properties and
impact strength of PLA96. SPS sterilization caused a significant (p<0.01) but small
decrease in tensile properties, but a more serious decrease of the impact strength
(p<0.01). The degradation characteristics of EO and SPS sterilized specimens were
similar to those of the NS specimens. GM sterilization and particularly RGS
sterilization seriously reduced the tensile properties and impact strength and affected
the specimens' degradation characteristics. SEM analysis showed increasing numbers
of nanopores (diameter < 100 nm) in all specimens with degradation time. The
surtace morphology of the GM specimens differed from that of the other specimens.
In conclusion, EO sterilization is recommended as sterilization method for
biodegradable PLA osteosyntheses.
Conclusions
The potential of PLA96 as a biodegradable osteosynthesis material is determined by
its mechanical and physical properties, as well as by its biocompatibility both
initially and during degradation. The mechanical properties of PLA96 are lost
relatively rapidiy after implantation. Therefore the clinical use of pLA96
osteosyntheses may be limited to applications under low biomechanical load.
However, the clinical performance of an osteosynthesis is not only dictated by the
material properties, but also by its design and dimensions that will influence the
degradation process. Ideally, each PLA osteosynthesis hould be individualized for
each specific clinical application. In this thesis, it was proved that PLA96 orbital
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